caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1548367444

A. Ramani Murugappan Arya

Family PracticeShinglehouse, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where A. Ramani Murugappan Arya's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 25 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CHARLES COLE MEMORIAL HOSPITAL4223,253
Eric Schreiber
Physician Assistant · Shinglehouse, PA
104281
NPI 136641820487308
Glauco Maresca
Diagnostic Radiology · Potsdam, NY
52135
AMERITOX, LLC49100
OLEAN GENERAL HOSPITAL40202
Saket Prasad
Internal Medicine · Coudersport, PA
36119
Brenda Wahlers
Hospitalist · Coudersport, PA
21150
CHARLES COLE MEMORIAL HOSPITAL2154
HERMANN, MARY2049
Michael Tarbox
Podiatry · Roulette, PA
2077
Muhammed Javed
Nephrology · Olean, NY
1995
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
9,290
Beneficiaries
—
Total drug cost
$637K
Distinct drugs
133
Brand share
22.7%
Top prescribed drugs
Atorvastatin Calcium617 claims
Lisinopril372 claims
Losartan Potassium323 claims
Amlodipine Besylate321 claims
Levothyroxine Sodium303 claims
QUALITY · MIPS · 2024
Final MIPS score
83.7
Quality
75.1
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.37%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.